Literature DB >> 3943441

Retrograde spreading of hydrocortisone enema in inflammatory bowel disease.

M Jay, G A Digenis, T S Foster, D R Antonow.   

Abstract

A hydrocortisone suspension enema was radiolabeled with [99mTc]technetium sulfur colloid and administered to four normal subjects and eight patients with varying degrees of inflammatory bowel disease. The extent of enema spreading was monitored using external scintigraphy for a period of up to 4 hr after administration. Pretreatment of normal subjects with an evacuation enema resulted in spreading of the radiolabeled enema throughout the entire colon. In seven of the eight patients studied, the enema migrated a distance equal to or greater than the extent of disease involvement. An in vivo stability study with an indium-111-labeled enema, using the perturbed angular correlation technique, revealed that the enema retains its stability for up to 90 min after administration. These results indicate that the use of hydrocortisone enemas may not be restricted to distal bowel disease, but may also be effective in inflammatory bowel diseases involving proximal regions of the colon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943441     DOI: 10.1007/bf01300698

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Systemic and local corticosteroid therapy in ulcerative colitis.

Authors:  S C TRUELOVE
Journal:  Br Med J       Date:  1960-02-13

2.  Cortisone in ulcerative colitis; preliminary report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1954-08-14

3.  Spread of steroid-containing foam after intrarectal administration.

Authors:  D J Hay; H Sharma; M H Irving
Journal:  Br Med J       Date:  1979-06-30

4.  Enema volume as an important factor in successful topical corticosteroid treatment of colitis.

Authors:  E T Swarbrick; H Loose; J E Lennard-Jones
Journal:  Proc R Soc Med       Date:  1974-08

5.  Retrograde colonic spread of sulphasalazine enemas.

Authors:  W Kruis; U Büll; J Eisenburg; G Paumgartner
Journal:  Scand J Gastroenterol       Date:  1982-10       Impact factor: 2.423

6.  Noninvasive dissolution measurement using perturbed angular correlation.

Authors:  R M Beihn; G A Digenis
Journal:  J Pharm Sci       Date:  1981-12       Impact factor: 3.534

7.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

Authors:  M J Farthing; M D Rutland; M L Clark
Journal:  Br Med J       Date:  1979-10-06
  7 in total
  7 in total

1.  Manufacture and properties of erythromycin beads containing neutron-activated erbium-171.

Authors:  A F Parr; G A Digenis; E P Sandefer; I Ghebre-Sellassie; U Iyer; R U Nesbitt; B M Scheinthal
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

Review 2.  Medical treatment of inflammatory bowel disease: new therapies, new drugs.

Authors:  L R Sutherland
Journal:  CMAJ       Date:  1987-11-01       Impact factor: 8.262

3.  Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas.

Authors:  M S McPhee; J T Swan; W L Biddle; N J Greenberger
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

4.  Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis.

Authors:  R A Vitti; F Meyers; L C Knight; J A Siegel; L S Malmud; R S Fisher
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

5.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

Authors:  J K Marshall; E J Irvine
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

Review 6.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

7.  Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.

Authors:  M Campieri; C Corbelli; P Gionchetti; C Brignola; A Belluzzi; G Di Febo; P Zagni; G Brunetti; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.